--2025/Q1-- / 12.977B--
--2024/Q4-- / 13.981B--
Oct 30, 20242024/Q311.439B / 12.119B--
Apr 30, 20242024/Q18.768B / 8.930B--
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 773.840
- -9.330-1.19%
Close Dec 30 16:00 ET
- 772.000
- -1.840-0.24%
Post 20:01 ET
734.62BMarket Cap83.66P/E (TTM)
779.760High771.000Low1.72MVolume777.915Open783.170Pre Close1.33BTurnover0.18%Turnover Ratio133.42P/E (Static)949.32MShares970.91652wk High51.59P/B733.04BFloat Cap605.62252wk Low5.03Dividend TTM947.28MShs Float970.916Historical High0.65%Div YieldTTM1.12%Amplitude5.278Historical Low774.603Avg Price1Lot Size
Eli Lilly and Co Key Stats
Eli Lilly and Co Q3 2024 Earnings Date
Overview | Lilly reported revenue of $11.4 billion, a 20% year-over-year increase, along with earnings per share (EPS) of $1.18, which fell short of Wall Street estimates
Currency：USDOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 12.12B | 11.44B | -679.50M |
| Miss Est. | +27.58% | +20.43% | -5.61% |
| EPS | 1.54 | 1.07 | -0.47 |
| Miss Est. | +2677.80% | +1883.33% | -30.70% |
Analyst Rating
Dec 20, 2024
Eli Lilly and Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Eli Lilly and Co Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
